FDA inspection
Rentschler Biopharma SE: FDA inspection ending May 23, 2017
FDA inspection 1022082 · Voluntary Action Indicated (VAI) · Laupheim
Key facts
| Inspection ID | 1022082 |
|---|---|
| Firm | Rentschler Biopharma SE |
| FEI number | 1000291122 |
| Address | Erwin-Rentschler-Str. 21 |
| City | Laupheim |
| Fiscal year | 2017 |
| Inspection end date | May 23, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data